 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
Volume 16, Number 24, Issue of December 15, 1996 pp. 8132-8139
Copyright ©1996 Society for NeuroscienceGDNF Selectively Protects Dopamine Neurons over Serotonin Neurons Against the Neurotoxic Effects of Methamphetamine
Received May 30, 1996; revised Sept. 24, 1996; accepted Sept. 27, 1996.
Wayne A. Cass Department of Anatomy and Neurobiology, University of Kentucky College of Medicine, Lexington, Kentucky 40536
Repeated methamphetamine (METH) administration to animals can result in long-lasting decreases in striatal dopamine (DA) and serotonin (5-HT) levels. Glial cell line-derived neurotrophic factor (GDNF) has pronounced effects on dopaminergic systems in vivo, including partial neuroprotective effects against 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine -induced lesions. The present study examined the ability of GDNF to prevent METH-induced reductions in potassium-evoked overflow of DA, and DA and 5-HT content, in striatum. GDNF (10 µg) or vehicle was injected into the right striatum of anesthetized rats. Twenty-four hours later, the rats were injected four times at 2 hr intervals with METH (5 mg/kg, s.c.) or saline. One week later, in vivo electrochemistry was used to monitor the overflow of DA evoked by local potassium application. Evoked overflow of DA was dramatically decreased in the striatum of METH-treated animals. GDNF prevented the reduction in evoked overflow of DA in the right striatum of the METH-treated animals. After each experiment, the animals were killed, and striatal DA and 5-HT levels determined by HPLC. The METH treatment produced significant decreases in both neurotransmitters. GDNF administration prevented the reduction in striatal DA levels on the treated side of the brain, whereas levels on the contralateral side were still decreased. In dose-response studies, 1 µg of GDNF was as protective as 10 µg, whereas 0.1 µg was only partially protective. In contrast, 5-HT levels were only minimally protected by previous administration of GDNF. These results suggest that GDNF can selectively protect DA neurons, compared with 5-HT neurons, against the neurotoxic effects of METH.
Key words: GDNF; methamphetamine; striatum; dopamine; serotonin; neurotrophic factor; in vivo electrochemistry; neurotoxicity
This article has been cited by other articles:
D.-Y. He and D. Ron
Glial Cell Line-derived Neurotrophic Factor Reverses Ethanol-mediated Increases in Tyrosine Hydroxylase Immunoreactivity via Altering the Activity of Heat Shock Protein 90
J. Biol. Chem., May 9, 2008; 283(19): 12811 - 12818.
[Abstract] [Full Text] [PDF]
H. A. Boger, L. D. Middaugh, K. S. Patrick, S. Ramamoorthy, E. D. Denehy, H. Zhu, A. M. Pacchioni, A.-C. Granholm, and J. F. McGinty
Long-Term Consequences of Methamphetamine Exposure in Young Adults Are Exacerbated in Glial Cell Line-Derived Neurotrophic Factor Heterozygous Mice
J. Neurosci., August 15, 2007; 27(33): 8816 - 8825.
[Abstract] [Full Text] [PDF]
J. L. CADET, S. JAYANTHI, and X. DENG
Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis
FASEB J, October 1, 2003; 17(13): 1775 - 1788.
[Abstract] [Full Text] [PDF]
R. Grondin, W. A. Cass, Z. Zhang, J. A. Stanford, D. M. Gash, and G. A. Gerhardt
Glial Cell Line-Derived Neurotrophic Factor Increases Stimulus-Evoked Dopamine Release and Motor Speed in Aged Rhesus Monkeys
J. Neurosci., March 1, 2003; 23(5): 1974 - 1980.
[Abstract] [Full Text] [PDF]
R. Grondin, Z. Zhang, A. Yi, W. A. Cass, N. Maswood, A. H. Andersen, D. D. Elsberry, M. C. Klein, G. A. Gerhardt, and D. M. Gash
Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys
Brain, October 1, 2002; 125(10): 2191 - 2201.
[Abstract] [Full Text] [PDF]
M. W. Barnett, C. E. Fisher, G. Perona-Wright, and J. A. Davies
Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan
J. Cell Sci., January 12, 2002; 115(23): 4495 - 4503.
[Abstract] [Full Text] [PDF]
Y. Wang, T. Hayashi, C.-F. Chang, Y.-H. Chiang, L.-I Tsao, T.-P. Su, C. Borlongan, and S.-Z. Lin
Methamphetamine Potentiates Ischemia/Reperfusion Insults After Transient Middle Cerebral Artery Ligation
Stroke, March 1, 2001; 32(3): 775 - 782.
[Abstract] [Full Text] [PDF]
E. D. Clarkson, J. Edwards-Prasad, C. R. Freed, and K. N. Prasad
Immortalized Dopamine Neurons: A Model to Study Neurotoxicity and Neuroprotection
Experimental Biology and Medicine, November 1, 1999; 222(2): 157 - 163.
[Abstract] [Full Text]
C. J. Phelps and D. L. Hurley
Pituitary Hormones as Neurotrophic Signals: Update on Hypothalamic Differentiation in Genetic Models of Altered Feedback
Experimental Biology and Medicine, October 2, 1999; 222(1): 39 - 58.
[Abstract] [Full Text]
W. A. Cass and M. W. Manning
Recovery of Presynaptic Dopaminergic Functioning in Rats Treated with Neurotoxic Doses of Methamphetamine
J. Neurosci., September 1, 1999; 19(17): 7653 - 7660.
[Abstract] [Full Text] [PDF]
W. A. Cass and M. W. Manning
GDNF Protection against 6-OHDA-Induced Reductions in Potassium-Evoked Overflow of Striatal Dopamine
J. Neurosci., February 15, 1999; 19(4): 1416 - 1423.
[Abstract] [Full Text] [PDF]
C. M. Kearns, W. A. Cass, K. Smoot, R. Kryscio, and D. M. Gash
GDNF Protection against 6-OHDA: Time Dependence and Requirement for Protein Synthesis
J. Neurosci., September 15, 1997; 17(18): 7111 - 7118.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|